[1]董 怡,马 静,余楠楠,等.大黄复方保留灌肠辅助治疗慢性肾脏病疗效及对患者生活质量的影响[J].陕西中医,2021,(7):910-913.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
　DONG Yi,MA Jing,YU Nannan,et al.Effect analysis of rhubarb compound retention enema adjuvant treatment of chronic kidney disease and its impact on patients' quality of life[J].,2021,(7):910-913.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.026]
点击复制

大黄复方保留灌肠辅助治疗慢性肾脏病疗效及对患者生活质量的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年7期
页码:
910-913
栏目:
临床研究
出版日期:
2021-07-09

文章信息/Info

Title:
Effect analysis of rhubarb compound retention enema adjuvant treatment of chronic kidney disease and its impact on patients' quality of life
作者:
董 怡; 马 静; 余楠楠; 王方圆; 薛松妍; 朱芳红; 赵行行; 储 霞; 姚 锐
(空军军医大学西京医院,陕西 西安 710032)
Author(s):
DONG Yi; MA Jing; YU Nannan; WANG Fangyuan; XUE Songyan; ZHU Fanghong; ZHAO Hanghang; CHU Xia; YAO Rui
(Xijing Hospital of Air Force Medical University,Xi'an 710032,China)
关键词:
慢性肾脏病;  大黄复方;  保留灌肠;  生活质量;  安全性
Keywords:
Rhubarb compound;  Retention enema;  Chronic kidney disease;  Quality of life;  Safety
分类号:
R 692
DOI:
DOI:10.3969/j.issn.1000-7369.2020.07.026
文献标志码:
A
摘要:
目的:研究大黄复方保留灌肠辅助治疗慢性肾脏病的治疗效果及对患者生活质量的影响。方法:纳入CKD患者170例,随机分为对照组和观察组,各85例。对照组患者进行常规对症治疗,观察组在对照组的基础上进行大黄复方保留灌肠。比较两组的治疗效果,治疗前后的GSRS评分以及生活质量评分。结果:两组的治疗有效率比较,差异无统计学意义(P>0.05)。对照组CKD分期进展率明显高于观察组(P<0.05)。治疗后,观察组反酸、腹胀、大便干结、恶心呕吐和嗳气评分均明显低于对照组(P<0.05),症状影响、躯体功能、情感生活、社会功能、社会角色、精力、肾病影响、疼痛、社会情感评分均明显高于对照组(P<0.05)。结论:大黄复方保留灌肠应用于CKD的辅助治疗中,疗效确切,有助于减缓疾病进展,减轻患者消化道症状,提高患者的生活质量。
Abstract:
Objective:To study rhubarb compound retention enema adjuvant treatment of chronic kidney disease and its impact on patients' quality of life.Methods:170 patients with CKD were included and randomly divided into a control group and an observation group,85 cases each.The patients in the control group received conventional symptomatic treatment,and the observation group received rhubarb compound enema on the basis of the control group.The treatment effect,GSRS score and quality of life score before and after treatment were compared between the two groups.Results:There was no statistically significant difference in treatment efficiency between the two groups(P>0.05).The CKD stage progression rate of the control group was significantly higher than that of the observation group(P<0.05).After treatment,the acid reflux,bloating,dry stool,nausea,vomiting and belching scores in the observation group were significantly lower than those in the control group(P<0.05).After treatment,the observation group's symptom effect,physical function,emotional life,social function,social role,energy,kidney disease effect,pain,and social affective score were significantly higher than the control group(P<0.05).Conclusion:The rhubarb compound retention enema has a definite effect on the treatment of CKD,which helps to slow down the disease progression,alleviate the patients' gastrointestinal symptoms and improve the patients' quality of life.

参考文献/References:

[1] 谢 婷,俞东容.慢性肾脏病中晚期的中医证候与治疗[J].中国中西医结合肾病杂志,2019,20(6):547-549.
[2] 姚硕硕,魏晓娜,籍大为,等.基于国医大师李佃贵“浊毒理论”治疗慢性肾衰竭的应用研究[J].陕西中医,2019,40(4):519-521.
[3] 刘汗清.中药保留灌肠联合口服营养补充治疗老年慢性肾脏病3期患者的疗效研究[D].武汉:湖北中医药大学,2019.
[4] 上海慢性肾脏病早发现及规范化诊治与示范项目专家组,高 翔,梅长林.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志,2017,37(1):28-34.
[5] 金 晟.丹参川芎嗪注射液联合中药灌肠对慢性肾脏病的疗效及作用机制研究[J].中国实验方剂学杂志,2013,19(8):287-289.
[6] 张丽霞.中医综合疗法对慢性肾衰竭患者生存质量影响的临床观察[D].咸阳:陕西中医药大学,2016.
[7] 杨 康,纪 越,赵庆云,等.慢性肾脏病与肠道微生态的关系、治疗策略及中医药干预研究[J].中医药学报,2019,47(1):1-6.
[8] 沈金峰,胡 芳,黄 伟,等.从浊邪论治慢性肾脏病[J].中华中医药学刊,2020,38(5):115-117.
[9] 赵建君,杨 娇,李 果.活血化瘀中药治疗衰竭期慢性肾衰竭患者疗效观察[J].陕西中医,2018,39(1):80-82.
[10] 王娴娴,沈沛成.“肠-肾轴”与慢性肾脏病[J].安徽中医药大学学报,2018,37(6):4-7.
[11] 张孟之,陈雨佳,王宗陵,等.基于对肠道菌群调节探讨大黄醒脑开窍机制[J].辽宁中医杂志,2019,46(6):1196-1198.
[12] 陈馥冰.复方大黄灌肠液灌肠治疗慢性肾脏病3-5期临床疗效的回顾性分析[D].广州:广州中医药大学,2019.
[13] 苏海华,滕佳琪,张家隆.结肠途径治疗对慢性肾脏病患者胃肠激素及胃肠动力的影响[J].中国中西医结合肾病杂志,2017,18(12):1058-1062.
[14] 李清萍.慢性肾脏病从“伏毒”论治[J].中国中医基础医学杂志,2020,26(1):32-34.
[15] 李燕珍,刘 億,赵海梅.中医药调控肠道菌群的研究进展与思考[J].中医研究,2018,31(11):72-77.
[16] 谢 晨,张亚楠,夏松辰.李建民从湿浊辨治慢性肾脏病特点分析[J].中华中医药杂志,2019,34(5):2201-2204.
[17] 钱虹利,谢丽萍,韦泉西.从脾肾论治慢性肾脏病研究进展[J].辽宁中医药大学学报,2018,20(12):154-156.
[18] 陈 琪,闵晶晶,王霄一,等.丹参酮ⅡA对慢性肾衰竭大鼠肾组织内质网应激相关分子GRP78、CHOP和Caspase-12表达的影响[J].中国中西医结合肾病杂志,2018,19(6):16-19,100.
[19] 陶 芳,孔 薇.基于肠-肾轴理论研究中药灌肠治疗慢性肾脏病机制的思路探讨[J].天津中医药,2019,36(10):973-976.
[20] 熊 利,伍亚舟,牟庆云,等.356例非透析慢性肾衰竭患者抑郁情况及生命质量的分析研究[J].第三军医大学学报,2019,41(2):163-169.

相似文献/References:

[1]屈 凯,王悦彤,王漱非,等.基于文献研究探讨益肾散结法防治肾小球硬化的理论内涵*[J].陕西中医,2019,(7):919.
　QU Kai,WANG Yuetong,WANG Shufei,et al.Based on literature research to explore the theoretical connotation of Kidney-reinforcing and Mass-disintegrating for prevention and treatment of glomerulosclerosis[J].,2019,(7):919.
[2]任永朋,华 琼,刘彦妍,等.中医“治未病”思想在防治肾脏病中的应用*[J].陕西中医,2019,(8):1101.
　REN Yongpeng,HUA Qiong,LIU Yanyan,et al.The application of the thought of “preventive treatment of disease” in the prevention and treatment of kidney disease in traditional Chinese medicine[J].,2019,(7):1101.
[3]张宏强,李桂霞,章彩凤,等.许筠治疗慢性肾病临床药对举隅*[J].陕西中医,2020,(6):808.[doi:DOI:10.3969/j.issn.10007369.2020.06.031]
[4]陈紫薇,陈 明△.从脾论治慢性肾脏病的生物学基础探讨*[J].陕西中医,2020,(11):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
　CHEN Ziwei,CHEN Ming..Discuss the biological foundation for chronic disease therapy from treatment through the spleen[J].,2020,(7):1627.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.029]
[5]齐 宁,宋姝西,刘香玉,等.参芪延肾方治疗慢性肾脏病疗效及对患者半乳糖缺陷IgA1、晚期糖基化终产物和微炎性反应状态的影响[J].陕西中医,2022,(5):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
　QI Ning,SONG Shuxi,LIU Xiangyu,et al.Effects of Shenqi Yanshen recipe on the levels of Gd-IgA1,AGEs and micro inflammatory response in patients with chronic kidney disease[J].,2022,(7):596.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.012]
[6]麦芳雄,张香兰,朱德礼.温肾健脾清化汤辅助治疗脾肾气虚型慢性肾脏病疗效及对患者血清转化生长因子β1、纤维连接蛋白水平的影响[J].陕西中医,2022,(8):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
　MAI Fangxiong,ZHANG Xianglan,ZHU Deli.Clinical efficacy of Wenshen Jianpi Qinghua decoction in the treatment of chronic kidney disease with spleen-kidney qi deficiency and its effect on serum transforming growth factor β1 and fibronectin levels[J].,2022,(7):1068.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.019]
[7]杨淑彬,李 婷,李晓妮,等.不同中药结肠透析模式对慢性肾脏病患者胃肠道症状和营养状态的影响[J].陕西中医,2022,(12):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
　YANG Shubin,LI Ting,LI Xiaoni,et al.Effects of different colon dialysis modes of traditional Chinese medicine on gastrointestinal symptoms and nutritional status in patients with chronic kidney disease[J].,2022,(7):1698.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.010]
[8]陈 曦,董凯旋,周 荣,等.中药调控p38丝裂原活化蛋白激酶/核因子κB通路治疗肾纤维化研究进展[J].陕西中医,2023,(7):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
　CHEN Xi,DONG Kaixuan,ZHOU Rong,et al.Research progress of traditional Chinese medicine regulating p38MAPK/NF-κB pathway in treatment of renal fibrosis[J].,2023,(7):980.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.036]
[9]周 林,禹 红,刘毓玲,等.活肾通络方联合依那普利对慢性肾脏病患者纤维化标志物、人附睾蛋白4水平的影响[J].陕西中医,2023,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]
　ZHOU Lin,YU Hong,LIU Yuling,et al.Effect of Huoshen Tongluo decoction and enalapril on renal function,fibrosis markers and HE4 levels in patients with chronic renal disease[J].,2023,(7):1400.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.014]
[10]王禹霖,刘梦超,郑冰洁,等.名中医张炳厚从瘀论治慢性肾脏病经验撷英[J].陕西中医,2023,(11):1602.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.026]
　WANG Yulin,LIU Mengchao,ZHENG Bingjie,et al.Experience of famous Chinese doctor Zhang Binghou treating chronic kidney disease by Yu[J].,2023,(7):1602.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.026]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81904006)
更新日期/Last Update: 2021-07-07